Skip to main content
FOCUSED ON IMPACT

We aim to boldly transform the ability to create new medicines

Our leadership
team

Cyrus Harmon, PhD

CEO and President

Cyrus Harmon, PhD

Patrick Salveson, PhD

Co-Founder, CTO

Patrick Salveson, PhD

Inca Dieterich, PhD

Co-Founder, VP, Business
Development

Inca Coman, PhD

Adam Moyer, PhD

Co-Founder, Director of
Design Research

Adam Moyer, PhD

Nao Hiranuma, PhD

Co-Founder, Director of
Machine Learning

Nao Hiranuma, PhD

Brian Hearn, PhD

VP, Chemistry

Brian Hearn, PhD

Anastasia Velentza, PhD

VP, Biology

Anastasia Velentza, PhD

Ben Sellers, PhD

VP, Computational Chemistry

Ben Sellers, PhD

David Kulp, PhD

VP, Informatics

David Kulp, PhD

Daniel Wright

Sr. Director of Operations

Daniel Wright

Our scientific
founders

David Baker, PhD

Co-Founder, Director, IPD
UW, Prof. Biochemistry

David Baker, PhD

Gaurav Bhardwaj, PhD

Co-Founder, UW, Asst. Prof.
Medicinal Chemistry

Gaurav Bhardwaj, PhD

Nao Hiranuma, PhD

Co-Founder, Director of
Machine Learning

Nao Hiranuma, PhD

Adam Moyer, PhD

Co-Founder, Director of
Design Research

Adam Moyer, PhD

Patrick Salveson, PhD

Co-Founder, CTO

Patrick Salveson, PhD

Lance Stewart, PhD, MBA

Co-Founder, CSO & COO, IPD

Lance Stewart, PhD, MBA

Our scientific
advisory board

Brian Shoichet, PhD

UCSF Prof. Pharmacy

Brian Shoichet, PhD

Jennifer Petter, PhD

Arrakis, Founder and Chief
Innovation Officer

Jennifer Petter, PhD

Philip Dawson, PhD

Scripps Research Professor
Chemistry

Philip Dawson, PhD

Frank McCormick, PhD, FRS, DSc (Hon)

UCSF, David A. Wood Distinguished Professorship of Tumor Biology and Cancer Research

Frank McCormick, PhD, FRS, DSc (Hon)

Our investors

Arch Venture Partners
Menlo Ventures
Madrona
NVentures
COMPUTE BEYOND NATURE
JOIN US

Connect

© 2024 Vilya, Inc.